<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>431 patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> of different venous system were evaluated for underlying acquired and inherited prothrombotic states </plain></SENT>
<SENT sid="1" pm="."><plain>Associated acquired risk factors were observed to be present in 28.7% patients and possible inherited in 32.3%, in the rest, no cause could be identified </plain></SENT>
<SENT sid="2" pm="."><plain>Major acquired risk factors included coexistence of <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> (12.2%), oral contraceptives (4.1%), puerperium (2.5%), <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> (2.3%) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (2%) </plain></SENT>
<SENT sid="3" pm="."><plain>Low levels of protein C were detected in 21.1% and of which 11.3% were attributed to acquired factors </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">Protein S deficiency</z:e> was found in 19.0% and of these 10.4% cases were associated with acquired risk factors </plain></SENT>
<SENT sid="5" pm="."><plain>Antithrombin III (AT III) deficiency was detected in 6.4% of patients, of which 4.8% were secondary to acquired factors </plain></SENT>
<SENT sid="6" pm="."><plain>In the rest, deficiency of protein C, protein S and AT III were attributed to inherited factors as no associated acquired risk factor was present </plain></SENT>
<SENT sid="7" pm="."><plain>Activated protein C resistance (APC-R) was present in 12.5% cases </plain></SENT>
</text></document>